The Cigna Group (CI)
NYSE: CI · Real-Time Price · USD
265.44
-2.98 (-1.11%)
At close: Dec 5, 2025, 4:00 PM EST
265.45
+0.01 (0.00%)
After-hours: Dec 5, 2025, 7:55 PM EST
The Cigna Group Market Cap
The Cigna Group has a market cap or net worth of $70.91 billion as of December 5, 2025. Its market cap has decreased by -20.94% in one year.
Market Cap
70.91B
Enterprise Value
98.04B
1-Year Change
-20.94%
Ranking
Category
Stock Price
$265.44
Market Cap Chart
Since December 1, 1998, The Cigna Group's market cap has increased from $15.96B to $70.91B, an increase of 344.18%. That is a compound annual growth rate of 5.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 71.70B | -6.65% |
| Dec 31, 2024 | 76.81B | -12.34% |
| Dec 29, 2023 | 87.63B | -13.50% |
| Dec 30, 2022 | 101.30B | 33.11% |
| Dec 31, 2021 | 76.11B | 1.19% |
| Dec 31, 2020 | 75.21B | -1.51% |
| Dec 31, 2019 | 76.36B | 65.10% |
| Dec 31, 2018 | 46.25B | -7.63% |
| Dec 29, 2017 | 50.07B | 46.21% |
| Dec 30, 2016 | 34.25B | -9.15% |
| Dec 31, 2015 | 37.69B | 40.03% |
| Dec 31, 2014 | 26.92B | 11.33% |
| Dec 31, 2013 | 24.18B | 58.21% |
| Dec 31, 2012 | 15.28B | 34.67% |
| Dec 30, 2011 | 11.35B | 14.27% |
| Dec 31, 2010 | 9.93B | 2.98% |
| Dec 31, 2009 | 9.64B | 110.64% |
| Dec 31, 2008 | 4.58B | -69.48% |
| Dec 31, 2007 | 15.00B | 11.15% |
| Dec 29, 2006 | 13.50B | -3.95% |
| Dec 30, 2005 | 14.05B | 28.29% |
| Dec 31, 2004 | 10.95B | 35.56% |
| Dec 31, 2003 | 8.08B | 40.94% |
| Dec 31, 2002 | 5.73B | -57.22% |
| Dec 31, 2001 | 13.40B | -34.02% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |